Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.

Source:http://linkedlifedata.com/resource/pubmed/id/12792431

Download in:

View as

General Info

PMID
12792431